Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 148430-81-3 | MDL No. : | MFCD18207677 |
Formula : | C4H8O4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZLYYZGDBMXPXOA-UHFFFAOYSA-N |
M.W : | 152.17 | Pubchem ID : | 21755243 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 30.36 |
TPSA : | 60.98 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.7 cm/s |
Log Po/w (iLOGP) : | 1.33 |
Log Po/w (XLOGP3) : | -0.66 |
Log Po/w (WLOGP) : | 0.44 |
Log Po/w (MLOGP) : | -0.93 |
Log Po/w (SILICOS-IT) : | -0.18 |
Consensus Log Po/w : | 0.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.24 |
Solubility : | 88.4 mg/ml ; 0.581 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.15 |
Solubility : | 108.0 mg/ml ; 0.713 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.26 |
Solubility : | 84.4 mg/ml ; 0.555 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.66 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With triethylamine In dichloromethane at 0 - 20℃; for 3 h; | To a solution of oxetan-3-ol (5 g, 67.5 mmol) and triethylamine (14.11 mL, 101 mmol) in DCM (150 mL) at 0°C was added methanesulfonyl chloride (6.79 mL, 88 mmol) dropwise. The mixture was stirred at RT for 3 hr. The solid was filtered off and the filtrate was washed with ice -water and brine solution. The organic phase was dried over anhydrous Na2S04 and concentrated in vacuo to afford the title compound (11.7 g, 67.5 mmol, 100percent yield) as an oil (containing 12.2 wtpercent of DCM). lU NMR (400 MHz, CDC13) δ 3.06 (s, 3H), 4.79-4.82 (m, 2H), 4.86-4.90 (m, 2H), 5.52-5.49 (m, 1H). |
75.7% | Stage #1: With triethylamine In dichloromethane at 0℃; for 0.333333 h; Stage #2: at 20℃; for 12 h; |
The oxetan-3-ol 16a (10.0 g, 135.0 mmol) was dissolved in dichloromethane (300 mL) at room temperature,After cooling to 0 ° C, triethylamine (20.4 g, 202.0 mmol) was added and stirred for 20 minutes.Methylsulfonyl chloride (20.08 g, 176.0 mmol) was added dropwise to the reaction solution and allowed to react at room temperature for 12 hours.The reaction solution was filtered and the filter cake was washed with dichloromethane (100 mL x 2), the organic phases were combined,Washed successively with water (200 mL x 1), saturated brine aqueous solution (200 mL x 1).Dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to give pale yellow solid 16b (15.6 g, yield 75.7percent). |
1.2 g | With triethylamine In dichloromethane at 20℃; for 2 h; Cooling with ice | To an ice-water cooled solution of oxetan-3-ol (1.0 g) in DCM (50 mL) was added TEA (3.8 mL). MsCI (1 .6 mL) was then added dropwise. The resulting mixture was warmed up slowly and stirred at RT for 2 hours. The mixture was then quenched with aq. NaHCO3 solutionand extracted with EA (3x50 mL). The combined organic phases were washed, dried and concentrated to afford oxetan-3-yl methanesulfonate (1.2 g). |
[ 16427-44-4 ]
2-Methoxyethyl methanesulfonate
Similarity: 0.85
[ 1379585-89-3 ]
Oxetan-3-yl trifluoromethanesulfonate
Similarity: 0.76
[ 1379585-89-3 ]
Oxetan-3-yl trifluoromethanesulfonate
Similarity: 0.76
[ 134419-59-3 ]
Tetrahydro-2H-pyran-4-yl methanesulfonate
Similarity: 0.70
[ 26272-83-3 ]
Oxetan-3-yl 4-methylbenzenesulfonate
Similarity: 0.51
[ 1379585-89-3 ]
Oxetan-3-yl trifluoromethanesulfonate
Similarity: 0.76
[ 26272-83-3 ]
Oxetan-3-yl 4-methylbenzenesulfonate
Similarity: 0.51